Lakefront Biotherapeutics NV (LKFT) — Defensive Interval Ratio
Lakefront Biotherapeutics NV (LKFT) has a Defensive Interval Ratio of 11210 days as of June 2026. Defensive assets of $2.16 Billion (cash $-, short-term investments $2.10 Billion, receivables $56.27 Million) cover 11210 days of daily cash needs of $192.59K/day. Explore long-term investment intensity of Lakefront Biotherapeutics NV to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Lakefront Biotherapeutics NV Defensive Interval Ratio (2022–2025)
This chart shows how Lakefront Biotherapeutics NV's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 11210 days, meaning defensive assets of $2.16 Billion can fund 11210 days of operations without new revenue. Read LKFT total debt and obligations for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for Lakefront Biotherapeutics NV (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Lakefront Biotherapeutics NV from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see how large is Lakefront Biotherapeutics NV's balance sheet.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 7076 days | $2.96 Billion | $418.80K/day | $- | $2.91 Billion | ▲ +3715 days |
| 2024 | 3361 days | $3.09 Billion | $918.03K/day | $- | $3.05 Billion | ▲ +348 days |
| 2023 | 3013 days | $3.54 Billion | $1.17 Million/day | $- | $3.52 Billion | ▲ +489 days |
| 2022 | 2525 days | $3.61 Billion | $1.43 Million/day | $- | $3.59 Billion | — |